Internal Medicine · Elk Grove, CA
NPI
1538141619
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
8110 Laguna Blvd
Elk Grove, CA, 95758
Phone (916) 683-3955
Groups this clinician bills Medicare through
Medicare paid, 2024
$87K
2,597 services
Medicare patients, 2024
420
Average age 74
Drug cost, 2024
$2.6M
10,027 prescriptions
Company payments, 2025
$36K
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paolo V Troia-Cancio was code 99214 (office e&m - established), 1,032 times for 367 patients. In total Paolo V Troia-Cancio billed 2,597 services in 45 codes, and Medicare paid $87K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-10-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,032 | 367 | $48.62 | $50K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 756 | 343 | $13.06 | $9,871 |
| 96372 Injection Administration | Office | 82 | 20 | $10.71 | $878 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 77 | 15 | $0.87 | $66.85 |
| G0008 Administration of influenza virus vaccine | Office | 73 | 71 | $34.15 | $2,493 |
| 99213 Office E&M - Established | Office | 65 | 56 | $45.82 | $2,978 |
| 90662 Vaccine Product | Office | 64 | 62 | $81.20 | $5,197 |
| 99442 Telephone Services | Office | 30 | 22 | $67.07 | $2,012 |
| 99232 Hospital E&M - Subsequent | Facility | 28 | 12 | $63.67 | $1,783 |
| 93005 Electrocardiogram | Office | 12 | 12 | $4.19 | $50.22 |
| 99443 Telephone Services | Office | 11 | 11 | $102.43 | $1,127 |
| 99222 Hospital E&M - Initial | Facility | 11 | 11 | $105.19 | $1,157 |
| 99204 Office E&M - New | Office | 11 | 11 | $69.83 | $768 |
By year: 2022 $108K for 3,224 services; 2023 $85K for 1,708 services; 2024 $87K for 2,597 services.
Medicare prescription drug claims, 2024
In 2024, the drug Paolo V Troia-Cancio prescribed most often to Medicare patients was Atorvastatin Calcium, with 726 prescriptions and refills. In total Paolo V Troia-Cancio wrote 10,027 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 726 | 1,825 | 200 | $7,622 |
| Amlodipine Besylate Generic | 447 | 1,083 | 123 | $2,395 |
| Gabapentin Generic | 287 | 543 | 72 | $10K |
| Lisinopril Generic | 252 | 634 | 67 | $1,985 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 252 | 260 | 52 | $7,144 |
| Losartan Potassium Generic | 242 | 574 | 70 | $2,533 |
| Tamsulosin Hcl Generic | 220 | 514 | 58 | $3,091 |
| Omeprazole Generic | 200 | 458 | 52 | $2,543 |
| Levothyroxine Sodium Generic | 184 | 482 | 50 | $2,678 |
| Duloxetine Hcl Generic | 159 | 292 | 39 | $3,322 |
| Trazodone Hcl Generic | 152 | 287 | 33 | $1,346 |
| Pantoprazole Sodium Generic | 145 | 292 | 38 | $2,254 |
| Metformin Hcl Generic | 136 | 346 | 42 | $1,526 |
| Metoprolol Succinate Generic | 127 | 327 | 36 | $1,866 |
| Eliquis Apixaban | 125 | 239 | 31 | $139K |
Brand drugs: 1,534 claims; generic drugs: 8,463 claims; opioid claims: 594.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paolo V Troia-Cancio $36K ($36K in general payments such as food, travel and fees) from 2 companies. The largest payer was Gilead Sciences, Inc. with $30K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.